Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of BDD Pharma.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
BDD Pharma
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
84 Castle Street Glasgow G4 0SF
Telephone
Telephone
+44 (0) 141 552 8791

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

CTx-2103 (Buspirone Hydrochloride) is a novel, trimodal, extended-release tablet of buspirone incorporating Cingulate’s proprietary PTR™ drug delivery platform, and is being studied for the treatment of anxiety and/or anxiety-related disorders.


Lead Product(s): Buspirone Hydrochloride

Therapeutic Area: Psychiatry/Psychology Product Name: CTx-2103

Highest Development Status: IND EnablingProduct Type: Small molecule

Recipient: Cingulate Therapeutics, LLC

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 24, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY